Call for Abstract
3rd International Conference on Neuro-Oncology and Brain Tumor, will be organized around the theme “Innovative Techniques and Advancements in Neuro-Oncology”
Neuro Oncology 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Neuro Oncology 2018
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
The Central Nervous System is denounced to various Malevolent disorders. Central Nervous System covers its mechanism, Metastatic pestilence, Ramification, Cancers, Neurons and Sensory Receptors, Neurological Disorders, Multiple scelosis and Imaging agents to CNS neurofibroma. Cancer spreads to the Nervous System by direct invasion or compression from continuous tissues relates to the proximity of the Nervous System to other structures.
Global Central Nervous System Drugs market to grow at a CAGR of -3.2% over the period 2011-2015. The global central nervous system (CNS) therapeutics peddle has been forecast to reach US$133 billion by the year 2018, which increases in disease ubiquity rates due to increase in population, introduction of new drugs, and increased outgo on healthcare.
- Track 1-1Central Nervous System
- Track 1-2Pathophysiology in Neuro Oncology
- Track 1-3Types of pain in Neuro Oncology
- Track 1-4Pediatric neurooncology
- Track 1-5Neurological Disorders
- Track 1-6Repeat Expansion Diseases
- Track 1-7Transverse Myelitis
- Track 1-8 Progressive Multifocal Leukoencephalopathy
- Track 1-9 Meningitis and Encephalitis
- Track 1-10 Neurosarcoidosis
- Track 1-11CNS lymphoma
- Track 1-12Motor Neuron Disease
- Track 1-13Neuro degenerative disorders and Injury
- Track 1-14Brain Injury Rehabilitation
Brain Tumor occurs when abnormal cells form within the brain. The symptoms of Brain stem tumors vary greatly and can include Ataxia, Cranial Nerve Palsy, headaches, problems with speech and swallowing, hearing loss, weakness, Hemiparesis, vision abnormalities, ptosis, and behavioural changes. Another possible symptom is vomiting. Any brain tumor is inherently serious and life-threatening because of its invasive and infiltrative character in the limited space of the Intracranial Cavity.
- Track 2-1Benign brain tumors
- Track 2-2Brain Prognosis
- Track 2-3Astrocytoma
- Track 2-4Oligodendroglioma
- Track 2-5 All Gliomas
- Track 2-6Prion diseases
- Track 2-7Medulloblastoma
- Track 2-8Craniopharyngioma
- Track 2-9Chordoma
- Track 2-10Tumor Biomarkers
- Track 2-11Imaging studies
- Track 2-12Malignant primary brain tumors
- Track 2-13Advanced Imaging of adult brain tumors
Neoplasm is an abnormal growth of tissue, which forms a mass that commonly referred to as a Tumor. Neoplasm can be caused by an Abnormal Proliferation of Tissues, that which can be caused by Genetic mutations. Not all types of Neoplasms cause a tumorous overgrowth of tissue. Malignant Neoplasms derived from epithelial cells are called Carcinomas.
- Track 3-1Glioma
- Track 3-2Glioblastoma Multiforme
- Track 3-3Ependymoma
- Track 3-4Pontine Glioma
- Track 3-5Vestibular schwannoma
- Track 3-6Unspecified glioma
- Track 3-7Astrocytoma
Neuroscience or Neural Science involves brain, spinal cord and nerves. Cellular Neuroscience and Molecular neuroscience involves the study of neurons at a cellular and molecular level. Clinical Neuroscience is a branch of neuroscience focussing on the diseases and disorders of the brain and central nervous system. Clinical neuroscience serves as a future of Psychiatry. Computational Neuroscience assists as a theoretical method for investigating the function and mechanism of the nervous system. It makes use of the essential features of the biological system at multiple spatial-temporal scales, from membrane currents, protein and chemical coupling to network oscillations and learning and memory.
- Track 4-1Neurophysiology
- Track 4-2Neuroanatomy
- Track 4-3Molecular Neuroscience
- Track 4-4Cellular Neuroscience
- Track 4-5Clinical Neuroscience
- Track 4-6Computational Neuroscience
Neurosurgery or neurological surgery is the medical specialty focused on the prevention, diagnosis, and rehabilitation of disorders which affect any part of the nervous system such as brain, spinal cord, peripheral nerves, and extra-cranial cerebrovascular system. They help in the diagnosis of intra cerebral hemorrhage.
- Track 5-1Cyber knife Radiosurgery
- Track 5-2Clinical Neurosurgery
- Track 5-3Traumatic injuries
- Track 5-4Hydrocephalus
- Track 5-5Cervical and Lumbar spinal stenosis
- Track 5-6Spinal Disc Herniation
- Track 5-7skull base surgery
- Track 5-8Pediatric Neurosurgery
- Track 5-9Funtional Neurosurgery
- Track 5-10Cerebrovascular Neurosurgery
- Track 5-11Spinal Neuro Surgery
Metastasis is defined as the process by which Cancer cells spread to other parts of the body. Metastatic Cancer is called as Stage IV cancer among many stages of it. Metastasis is one of the hallmarks of cancer distinguishing it from benign tumors. And it can spread to distant parts of the body.
- Track 6-1Metastases neoplastic
- Track 6-2Intracranial Metastasis
- Track 6-3Causes and Symptoms of metastatic tumors
- Track 6-4Malignant melanoma
- Track 6-5Optic nerve glioma
- Track 6-6Melanoma (skin cancer) and metastatic brain tumors
- Track 6-7Kidney cancer and metastatic brain tumors
- Track 6-8Lung cancer and metastatic brain tumors
- Track 6-9Metastases base of skull
- Track 6-10Meningitis
- Track 6-11Inter- intra tumour heterogeneity
Meningioma is referred to as slow growing Brain tumors, but their origin is not from the Brain tissue. Meningiomas are often benign tumors arising from the Arachnoidal cells of Meninges of the brain and spinal cord.
Meningiomas usually grow inward slowly, causing pressure on the Brain or Spinal cord. They interfere with the normal functions of the Brain after reaching a large size. They represent about one-third of all Primary Brain Tumors and occur most frequently in middle-aged women.
- Track 7-1Abnormal Chromosome 22
- Track 7-2Platelet-Derived Growth Factor (PDGFR)
- Track 7-3Epidermal Growth Factor Receptors (EGFR)
- Track 7-4Skull base meningioma
- Track 7-5Spinal cord tumor in children
Gangliocytomas are rare indolent CNS tumours which are made up of mature neurons arising anywhere within the Neuroaxis. They differ from gangliogliomas as they lack neoplastic glial cells. Treatment involves surgical removal of the tumor. These are Neuroepithelial Tumors which line the ventricles of the brain and produces Cerebrospinal fluid.
- Track 8-1Ganglioneuroma
- Track 8-2Headache
- Track 8-3Seizures
- Track 8-4Cognitive problems
- Track 8-5Hormonal disorders
Choroid Plexus Tumor arises from Brain tissue that invades nearby tissue and spread widely via the cerebrospinal fluid. Like other brain tumors, choroid plexus tumors are also “graded.” Like other Brain Tumors, Choroid Plexus Tumors are also “graded.” Choroid Plexus Neoplasms are rare, Intraventricular, Primary Central Nervous System (CNS) tumors derived from Choroid Plexus Epithelium that are seen predominantly in children.
- Track 9-1Choroid Plexus Papilloma (grade 1)
- Track 9-2Intermediate Grade (grade 2)
- Track 9-3Atypical Choroid plexus papilloma (grade 3)
A Brainstem glioma is an aggressive and dangerous Cancerous Glioma Tumor in the brainstem which starts in the Brain or Spinal cord tissue and typically spread throughout the Nervous System. It is more diagnosed in children and young adults under the age of twenty. Symptoms of Brainstem glioma can develop slowly and subtly and may go unnoticed for months. A sudden onset of symptoms tends to occur with more rapidly growing, high-grade tumors. In other cases, the symptoms may arise abruptly. Unlike most Brain tumors, Brainstem Glioma is not often treated with Neurosurgery due to complications in vital parts of the Brain. Without treatment, the life expectancy is typically a few months from the time of diagnosis.
- Track 10-1Diffuse intrinsic pontine glioma
- Track 10-2Focal or low-grade glioma
- Track 10-3Radiation therapy with radio sensitizers
- Track 10-4Loss of balance and Trouble walking
- Track 10-5Vision and Hearing Problems
- Track 10-6Nausea and Vomiting
- Track 10-7Unusual Sleepiness
The Psychosocial and Neurocognitive functioning of several cancer patients and survivors deleteriously affected by various treatments of Malignant tumors such as Chemotherapy, Radiotherapy and Hormonal therapy. Oncology researchers and Clinicians are increasingly Cognizant of the negative effects of Cancer and its treatments on the Brain and its mental processes and Cognitive outcomes.
Neuropsychology in Cancer features the current findings on the Neuropsychological effects of the Cancers and their treatments along with the most promising Neuropsychological and behavioural health interventions available to mitigate these deficits.
- Track 11-1Incognition
- Track 11-2Bipolar disorder
- Track 11-3Neuropsychiatric Disorders
- Track 11-4Animal Behavior
- Track 11-5Sensory Processing
- Track 11-6Sleep and Communication
- Track 11-7Learning and Memory
- Track 11-8Addiction
- Track 11-9Evolutionary Psychology
- Track 11-10Psycho-metrics
- Track 11-11Neuropsychological Impairment
- Track 11-12Cognitive testing
- Track 11-13Brain-stimulation treatments
Para Neoplastic Neurological Syndromes (PNS) are defined as the remote effects of cancer on the Nervous System. They are due to the presence of Cancer and exclusion of other known causes of the Neurological symptoms, but this criterion does not separate “true” PNS from Neurological syndromes that are coincidental with a Cancer.
- Track 12-1 Metastasis
- Track 12-2 Encephalomyelitis
- Track 12-3 Para Neoplastic Neurologic Autoimmunity
- Track 12-4Neuraxis
The Response Assessment in Neuro-Oncology (RANO) Working Group is an international, Multidisciplinary effort to develop new standardized response criteria for Clinical trials in Brain tumors. The Surgery Working Group of RANO identified surgically related End-point evaluation problems that were not addressed in the original Macdonald criteria. Macdonald criteria led to the initiation of an International effort in Neurooncology to develop Novel Response and Progression Assessment Criteria.
- Track 13-1 Cerebrovascular Disease
- Track 13-2Computational Neuroscience
- Track 13-3Response Evaluation
- Track 13-4Trauma and Tumour
- Track 13-5Clinical Neuroscience
- Track 13-6Macdonald Criteria
- Track 13-7Clinical Trials
- Track 13-8Clinical Psychology
In low-grade Gliomas, stereotactically guided conformal Radiotherapy should lead to a significant reduction in Radiation-associated late toxicity, while in selected groups of high-grade Gliomas the use of adjuvant or Neo-adjuvant Chemotherapy may improve survival. In primitive Neuroectodermal Tumours Prognostic Biological markers have been identified that are undergoing prospective evaluation. In infants the use of post-surgical chemotherapy alone may allow the postponing of Radiotherapy in selected cases. For patients with localized Medulloblastomas a new standard treatment is emerging that uses reduced-dose Craniospinal Radiotherapy followed by Platinum-based chemotherapy, while in Supratentorial primitive Neuroectodermal tumours future treatment will be aimed at improving local control.
- Track 14-1Central Nervous System Malignancies
- Track 14-2Primitive Neuroectodermal Tumours
- Track 14-3platinum-based chemotherapy
- Track 14-4Whole-brain radiotherapy (WBRT)
The upcoming implementation of a Neurosurgical ablation device that provides controlled therapy for brain lesions those are difficult to reach and treat. This tool, will allow us to introduce the probe into the tumor and destroy it without having to perform a Surgical Operation or Craniotomy.
Recent advances have made treatment for brain tumors much safer and more successful. Some of these newer techniques include:
•Antiseizure/Antiepileptic Drugs (AEDs)
•Surgery: The goal of surgery in the treatment of metastasis is to maximally remove tumor while leaving patients with good function
•Radiosurgery: A non-invasive technique that delivers numerous narrow, precisely aimed, highly focused beams of ionizing radiation that converge at a specific point.
•Radiation therapy: X-rays and other forms of radiation can destroy tumor cells or delay tumor growth.
•Chemotherapy: The use of drugs to kill rapidly dividing cells. It can be taken orally or intravenously.
•Targeted therapy: The focus on a specific element of a cell, such as molecules or pathways required for cell growth, in order to use them as a target.
- Track 15-1Computer-Assisted Technology
- Track 15-2Endoscopy
- Track 15-3Intraoperative Magnetic Resonance Imaging (MRI)
- Track 15-4Personalized Vaccines
- Track 15-5Genomic Sequencing
The following are the steps involved in Brain Tumor Diagnosis;
· A neurological exam: A neurological exam may include, among other things, checking your vision, hearing, balance, coordination, strength and reflexes. Difficulty in one or more areas may provide clues about the part of your brain that could be affected by a brain tumor.
· Imaging tests: Magnetic Resonance Imaging (MRI) is commonly used to help diagnose brain tumors. In some cases a dye may be injected through a vein in your arm during your MRI study.
A number of specialized MRI scan components — including functional MRI, perfusion MRI and Magnetic Resonance Spectroscopy
· Tests to find cancer in other parts of your body: If it's suspected that your Brain tumor may be a result of Cancer that has spread from another area of your body, your doctor may recommend tests and procedures to determine where the cancer originated. One example might be a CT scan of the chest to look for signs of Lung Cancer.
· Collecting and testing a sample of abnormal tissue (biopsy): A Biopsy can be performed as part of an operation to remove the Brain tumor, or a Biopsy can be performed using a needle.
A stereotactic needle biopsy may be done for brain tumors in hard to reach areas or very sensitive areas within your brain that might be damaged by a more extensive operation. Your Neurosurgeon drills a small hole into your skull. A thin needle is then inserted through the hole. Tissue is removed using the needle, which is frequently guided by CT or MRI scanning.
The Biopsy sample is then viewed under a microscope to determine if it is cancerous or benign. This information is critical to establish a diagnosis and prognosis and, most importantly, in guiding treatment.
- Track 16-1 Neurologic Exam
- Track 16-2 MRI
- Track 16-3CT Scan
- Track 16-4Spinal Tap
- Track 16-5Biopsy
Neuroradiology uses primary imaging modalities including computed tomography (CT) and magnetic resonance imaging (MRI) to focus on Endovascular or minimally invasive diagnosis and characterization of abnormalities of the Central Nervous System or head and neck lesions such as Tumors, Aneurysms, Vascular malformations, or Stroke. It involves different types of Imaging Studies like Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) for characterization of various Neurological disorders.
- Track 17-1Positron Emission Tomography (PET)
- Track 17-2Intensity modulated radiation therapy(IMRT)
- Track 17-3Palliative radiotherapy in Neuro Oncology
- Track 17-4Cellular Radiation Oncology
- Track 17-5Molecular Radiation Oncology
- Track 17-6Radioactive compounds in NeuroImaging
- Track 17-7Clinical Radiation Oncology
- Track 17-8Vincristine
- Track 17-9Stereotactic Radiosurgery
- Track 17-10Magneto Encephalography (MEG)
- Track 17-11Quality Measures of Radiotherapy
The Immunotherapy treats the Immune system in Injury and repair during wide range of Neurological disorders, Inflammatory and Autoimmune Diseases of the Nervous system such as Multiple Sclerosis (MS) and Neuromyelitis Optical (NMO) and several Brain Tumor conditions. There were numerous Radiological studies to improve Diagnosis and treatment of these diseases. The main focus is to develop the so-called Neuroprotective (nerve cell protecting) treatment approaching and establishing Modern examination procedures such as MRI (Magnetic Resonance Imaging), OCT (Optical Coherence Tomography) and Motion Analysis.
- Track 18-1 Neuroinflammation
- Track 18-2Neuroendocrine Immunology
- Track 18-3Clinical Neuroimmunology
- Track 18-4Neuroimmunlogical Disorders
- Track 18-5Rituximab
Neuroimaging is the Mapping of human Brain using functional Magnetic Resonance Imaging (fMRI). It determines how difference and change in Cerebral structure, complexly relates to Behavior and Cognition at Multiple levels of Analysis. It includes Multimodality imaging like CT, MRI, PET, to offer most precise information noninvasively, on type of the Tumor and grade; it also guides therapeutic choices and also assesses the effects of therapy
Neuroimaging development, testing, and implementation of advanced MRI and PET Imaging biomarkers for the characterization of Brain Tumor biology and response evaluation in Clinical trials able to detect the biological behaviour of Brain Tumor more accurately.
- Track 19-1Cranial ultrasound
- Track 19-2Single-Photon Emission Computed Tomography
- Track 19-3Brain Mapping
- Track 19-4Diffuse Optical Imaging
- Track 19-5Computed Axial Tomography
- Track 19-6Comparison Of Imaging Types
A Metastatic Cancer is one which has spread from the primary site of origin into different area of the body. That occur in about one-fourth of all cancers that spread through the body. Treatment for Metastatic Cancer aims to slow the growth or spread of the Cancer. Treatment depends on the type of cancer, where it started, the size and location of the Metastasis, and other factors.
The primary tumor may be found by examining tumor tissues from the brain. Tests may include; Cerebral Angiography, Mammogram, Chest x-ray, CT scans of the Chest, Abdomen, and Pelvis to find the original tumor site, MRI of the Brain, Lumbar puncture, EEG.
- Track 20-1Treatment Algorithm
- Track 20-2Dexamethasone
- Track 20-3Famotidine
- Track 20-4Trimethoprim-Sulfamethoxazole
Occurrence of Cancer related complications are seen during Chemotherapy because the dividing blood cells in bone marrow are also prone to damage from medications used in treatment also many of these side effects can be attributed to low blood counts. In rare cases, some Chemotherapy drugs can cause Heart damage or trigger another cancer such as Leukaemia. Some complications seen are
- sleep disturbances
Preventive measures should start before cancer therapy begins, reducing the occurrence of further problems brought about by different treatment modalities.
- Track 21-1Disease Seizures
- Track 21-2Increased Intracranial Pressure
- Track 21-3Thromboembolism
- Track 21-4Neutropenia
- Track 21-5Thrombocytopenia
- Track 21-6Neutropenia
- Track 21-7Anaemia
- Track 21-8Encephalopathy
- Track 21-9CNS Infections
To study the effect of drugs on the cellular function in nervous system is called as Neuropharmacology. It is of two types such as; Behavioral neuropharmacology and Molecular neuropharmacology. It explains the drug dependence and addiction effect of brain. The science dealing with the study of the effects of the poisons on the nervous system is called as Neuro toxicology. It happens when nervous system gets affected by the neurotoxins. It occurs due to the exposure of the chemotherapy, radiation treatment, drug abuse, pesticides etc.
- Track 22-1Neurotransmitter
- Track 22-2Tuberomammillary nucleus
- Track 22-3Surgical mangement for brain tumors
- Track 22-4Genetic Heterogeneity in Neuro Oncology
- Track 22-5Chemotherapy
- Track 22-6cancer Drugs
- Track 22-7Neuroendocrinology and Stroke
- Track 22-8Behavioral Neuropharmacology
- Track 22-9Neuroanesthesia
- Track 22-10Molecular Neuropharmacology
- Track 22-11Clinical Neuropharmacology
- Track 22-12Chemotherapy
- Track 22-13Neurotoxin
- Track 22-14Neuromodulator
- Track 22-15Drug compounds targeting Tumor metabolism
Neurological Nursing is a nursing specialty dealing with assessment, nursing diagnosis and management of brain and nervous system disorders, tumors, brain injuries, trauma, spine injuries, stroke, seizures aneurysms and many more conditions. Critical illness defines severe damage of vital organs like Central nervous system failure, brain damage, and spine injury and there is a chance of life threatening deterioration in the patient’s condition. Critical care is time dependent and delivered by physician to a critically injured patient and requires high complex decision to assess, monitor, manipulate and support vital organ function in order to treat vital organ system failure.
- Track 23-1Neurology and Nursing
- Track 23-2Brain Nursing
- Track 23-3Mental Health Nursing
- Track 23-4Addiction Nursing
- Track 23-5Neuro Nurse Practise Guidence
- Track 23-6Neurovascular Nursing
- Track 23-7Geriatric Nursing
- Track 23-8Pediatrics Nursing
- Track 23-9Advance Nursing Practice
- Track 24-1Clinical trials and case studies in Pediatric Neurology
- Track 24-2Pediatric Psychological Disorders and Neuropsychiatric D
- Track 24-3Pediatric Nursing and Care
- Track 24-4Pediatric Neurosurgery
- Track 24-5Pediatric Neuroimaging
- Track 24-6Pediatric Neurogenetics and Neurodegenerative Disorders
- Track 24-7Pediatric Neuro-Oncology
- Track 24-8Pediatric Neuro-immunology Disorders
- Track 24-9Pediatric Movement Disorders
- Track 24-10Neuro ophthalmology and Sleep disorders
- Track 24-11Pediatric Pharmacology and Drug therapy